InvestorsHub Logo
Followers 26
Posts 4067
Boards Moderated 0
Alias Born 12/26/2018

Re: thefamilyman post# 378966

Saturday, 10/16/2021 5:18:02 PM

Saturday, October 16, 2021 5:18:02 PM

Post# of 403047
If you have one government customer? Sure it's possible. Drop it on their doorstep and let the military handle it.

I was talking about after we get that payment and EUA. Getting Brilacidin to every hospital on Earth will take more expertise than we could hire in a reasonable timeframe.

With $1B in the bank and significant demand we wouldn't be talking a 20-25% royalty. A 50% royalty like BioNTech is getting would be more appropriate.

The goal would be to maximize sales while COVID is still a thing. If it took six months to a year to really get operations up to speed that could be $10B lost (REGN antibody revenues for the year). Better to lock in that $5B share and then IPIX does whatever it wants with every indication in the pipeline.

COVID probably won't be around forever.

2022: $10B market
2023: $2B market

I'd rather have 50% of both year rather than 100% of the second.

$1B cash is worth quite a lot to us.

Go IPIX!


Brilacidin! The hottest COVID-19 drug of 2023.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News